Internalization of NK cells into tumor cells requires ezrin and leads to programmed cell-in-cell death

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Cytotoxic lymphocytes, including natural killer (NK) cells, are crucial for eliminating defective and cancerous cells.
• Previous research indicated NK cells can enter tumor cells, but their fate and the mechanism's distinctiveness remained unclear.
• The homotypic cell-in-cell process, known as entosis, involves cells engulfing other cells of the same type.

Purpose of the Study:

• To elucidate the fate of NK cells after internalizing into tumor cells.
• To determine if this heterotypic cell-in-cell process differs from entosis.
• To identify key molecular regulators involved in NK cell internalization into tumor cells.

Main Methods:

• Real-time dual-color imaging to visualize NK cell entry into tumor cells.
• Assays for apoptosis (caspase 3 activation, DNA fragmentation) to confirm cell death.
• siRNA-based knockdown to identify essential protein factors.
• Use of caspase inhibitor (Z-VAD-FMK) to validate apoptosis.

Main Results:

• NK cells internalize into tumor cells and subsequently undergo apoptosis, confirmed by caspase 3 activation and DNA fragmentation.
• This NK cell death pathway is distinct from the previously described entosis process.
• The actin cytoskeletal regulator, ezrin, plays a critical role in mediating NK cell internalization.
• Protein kinase A (PKA)-mediated phosphorylation of ezrin enhances NK cell internalization.

Conclusions:

• NK cells engage in a unique cell-in-cell process leading to their apoptotic demise within tumor cells.
• Ezrin is a key regulator of NK cell internalization, with PKA-mediated phosphorylation enhancing this process.
• These findings reveal a novel mechanism of NK cell interaction with tumor cells with implications for cancer immunotherapy.